AAAAAA

   
Results: 1-20 |
Results: 20
THE DARTMOUTH REGIMEN - GONE OR GOING STRONG
Authors: MCCLAY EF BERD D MASTRANGELO MJ
Citation: Ef. Mcclay et al., THE DARTMOUTH REGIMEN - GONE OR GOING STRONG, Cancer investigation, 16(6), 1998, pp. 421-423
CHARACTERIZATION OF A SUSTAINED-RELEASE DELIVERY SYSTEM FOR COMBINED CYTOKINE PEPTIDE VACCINATION USING A POLY-N-ACETYL GLUCOSAMINE-BASED POLYMER MATRIX/
Authors: COLE DJ GATTONICELLI S MCCLAY EF METCALF JS BROWN JM NABAVI N NEWTON DA WOOLHISER CB WILSON MC VOURNAKIS JN
Citation: Dj. Cole et al., CHARACTERIZATION OF A SUSTAINED-RELEASE DELIVERY SYSTEM FOR COMBINED CYTOKINE PEPTIDE VACCINATION USING A POLY-N-ACETYL GLUCOSAMINE-BASED POLYMER MATRIX/, Clinical cancer research, 3(6), 1997, pp. 867-873
SYNERGY BETWEEN TAMOXIFEN AND CISPLATIN IN HUMAN-MELANOMA CELLS IS DEPENDENT ON THE PRESENCE OF ANTIESTROGEN-BINDING SITES
Authors: JONES JA ALBRIGHT KD CHRISTEN RD HOWELL SB MCCLAY EF
Citation: Ja. Jones et al., SYNERGY BETWEEN TAMOXIFEN AND CISPLATIN IN HUMAN-MELANOMA CELLS IS DEPENDENT ON THE PRESENCE OF ANTIESTROGEN-BINDING SITES, Cancer research, 57(13), 1997, pp. 2657-2660
A PHASE-I AND PHARMACOKINETIC STUDY OF HIGH-DOSE TAMOXIFEN AND WEEKLYCISPLATIN IN PATIENTS WITH METASTATIC MELANOMA
Authors: MCCLAY EF MCCLAY MET JONES JA WINSKI PJ CHRISTEN RD HOWELL SB HALL PD
Citation: Ef. Mcclay et al., A PHASE-I AND PHARMACOKINETIC STUDY OF HIGH-DOSE TAMOXIFEN AND WEEKLYCISPLATIN IN PATIENTS WITH METASTATIC MELANOMA, Cancer, 79(5), 1997, pp. 1037-1043
MELANOMA - INTRODUCTION
Authors: MCCLAY EF
Citation: Ef. Mcclay, MELANOMA - INTRODUCTION, Seminars in oncology, 23(6), 1996, pp. 649-649
SYSTEMIC CHEMOTHERAPY FOR THE TREATMENT OF METASTATIC MELANOMA
Authors: MCCLAY EF MCCLAY MET
Citation: Ef. Mcclay et Met. Mcclay, SYSTEMIC CHEMOTHERAPY FOR THE TREATMENT OF METASTATIC MELANOMA, Seminars in oncology, 23(6), 1996, pp. 744-753
DELTA(12)-PROSTAGLANDIN-J(2) IS CYTOTOXIC IN HUMAN MALIGNANCIES AND SYNERGIZES WITH BOTH CISPLATIN AND RADIATION
Authors: MCCLAY EF WINSKI PJ JONES JA JENNERETTE J GATTONICELLI S
Citation: Ef. Mcclay et al., DELTA(12)-PROSTAGLANDIN-J(2) IS CYTOTOXIC IN HUMAN MALIGNANCIES AND SYNERGIZES WITH BOTH CISPLATIN AND RADIATION, Cancer research, 56(17), 1996, pp. 3866-3869
DETERMINANTS OF TAMOXIFEN SENSITIVITY CONTROL THE NATURE OF THE SYNERGISTIC INTERACTION BETWEEN TAMOXIFEN AND CISPLATIN
Authors: MCCLAY EF JONES JA WINSKI PJ ALBRIGHT KD CHRISTEN RD HOWELL SB
Citation: Ef. Mcclay et al., DETERMINANTS OF TAMOXIFEN SENSITIVITY CONTROL THE NATURE OF THE SYNERGISTIC INTERACTION BETWEEN TAMOXIFEN AND CISPLATIN, Cancer research, 56(17), 1996, pp. 3993-3997
A PHASE-II TRIAL OF INTRAPERITONEAL HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR SUPPORT IN PATIENTS WITH OVARIAN-CARCINOMA
Authors: MCCLAY EF BRALY PD KIRMANI S PLAXE SC KIM S MCCLAY ME WILGUS L HOWELL SB
Citation: Ef. Mcclay et al., A PHASE-II TRIAL OF INTRAPERITONEAL HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR SUPPORT IN PATIENTS WITH OVARIAN-CARCINOMA, American journal of clinical oncology, 18(1), 1995, pp. 23-26
CURRENT CLINICAL-PRACTICE - CUTANEOUS MELANOMA - HOW MUCH SURGERY IS ENOUGH - RESPONSE
Authors: MCCLAY EF
Citation: Ef. Mcclay, CURRENT CLINICAL-PRACTICE - CUTANEOUS MELANOMA - HOW MUCH SURGERY IS ENOUGH - RESPONSE, Seminars in oncology, 22(2), 1995, pp. 23-23
TAMOXIFEN AND CHEMOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA - ARE THERE OTHER POSSIBLE MECHANISMS EXPLAINING THEIR POTENTIATION - REPLY
Authors: MCCLAY EF MCCLAY MET
Citation: Ef. Mcclay et Met. Mcclay, TAMOXIFEN AND CHEMOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA - ARE THERE OTHER POSSIBLE MECHANISMS EXPLAINING THEIR POTENTIATION - REPLY, Journal of clinical oncology, 12(9), 1994, pp. 1996-1996
TAMOXIFEN - IS IT USEFUL IN THE TREATMENT OF PATIENTS WITH METASTATICMELANOMA
Authors: MCCLAY EF MCCLAY MET
Citation: Ef. Mcclay et Met. Mcclay, TAMOXIFEN - IS IT USEFUL IN THE TREATMENT OF PATIENTS WITH METASTATICMELANOMA, Journal of clinical oncology, 12(3), 1994, pp. 617-626
A COMPARISON OF INTRAVENOUS VERSUS INTRAPERITONEAL CHEMOTHERAPY FOR THE INITIAL TREATMENT OF OVARIAN-CANCER
Authors: KIRMANI S BRALY PS MCCLAY EF SALTZSTEIN SL PLAXE SC KIM S CATES C HOWELL SB
Citation: S. Kirmani et al., A COMPARISON OF INTRAVENOUS VERSUS INTRAPERITONEAL CHEMOTHERAPY FOR THE INITIAL TREATMENT OF OVARIAN-CANCER, Gynecologic oncology, 54(3), 1994, pp. 338-344
A PHASE-I TRIAL OF INTRAPERITONEAL CARBOPLATIN AND ETOPOSIDE WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR SUPPORT IN PATIENTS WITHINTRAABDOMINAL MALIGNANCIES
Authors: MCCLAY EF BRALY PD KIRMANI S PLAXE SC MCCLAY ME WILGUS L KIM S HOWELL SB
Citation: Ef. Mcclay et al., A PHASE-I TRIAL OF INTRAPERITONEAL CARBOPLATIN AND ETOPOSIDE WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR SUPPORT IN PATIENTS WITHINTRAABDOMINAL MALIGNANCIES, Cancer, 74(2), 1994, pp. 664-669
TAMOXIFEN DELAYS THE DEVELOPMENT OF RESISTANCE TO CISPLATIN IN HUMAN-MELANOMA AND OVARIAN-CANCER CELL-LINES
Authors: MCCLAY EF ALBRIGHT KD JONES JA CHRISTEN RD HOWELL SB
Citation: Ef. Mcclay et al., TAMOXIFEN DELAYS THE DEVELOPMENT OF RESISTANCE TO CISPLATIN IN HUMAN-MELANOMA AND OVARIAN-CANCER CELL-LINES, British Journal of Cancer, 70(3), 1994, pp. 449-452
PHASE-I PHARMACOKINETIC STUDY OF HIGH-DOSE PROGESTERONE AND DOXORUBICIN
Authors: CHRISTEN RD MCCLAY EF PLAXE SC YEN SSC KIM S KIRMANI S WILGUS LL HEATH DD SHALINSKY DR FREDDO JL BRALY PS OQUIGLEY J HOWELL SB
Citation: Rd. Christen et al., PHASE-I PHARMACOKINETIC STUDY OF HIGH-DOSE PROGESTERONE AND DOXORUBICIN, Journal of clinical oncology, 11(12), 1993, pp. 2417-2426
PROFILES OF WOMEN AGE 30-39 AND AGE LESS-THAN 30 WITH EPITHELIAL OVARIAN-CANCER - REPLY
Authors: PLAXE SC BRALY PS FREDDO JL MCCLAY EF KIRMANI S HOWELL SB
Citation: Sc. Plaxe et al., PROFILES OF WOMEN AGE 30-39 AND AGE LESS-THAN 30 WITH EPITHELIAL OVARIAN-CANCER - REPLY, Obstetrics and gynecology, 82(4), 1993, pp. 637-638
TAMOXIFEN MODULATION OF CISPLATIN CYTOTOXICITY IN HUMAN MALIGNANCIES
Authors: MCCLAY EF ALBRIGHT KD JONES JA CHRISTEN RD HOWELL SB
Citation: Ef. Mcclay et al., TAMOXIFEN MODULATION OF CISPLATIN CYTOTOXICITY IN HUMAN MALIGNANCIES, International journal of cancer, 55(6), 1993, pp. 1018-1022
TAMOXIFEN MODULATION OF CISPLATIN RESISTANCE IN PATIENTS WITH METASTATIC MELANOMA - A BIOLOGICALLY IMPORTANT OBSERVATION
Authors: MCCLAY EF MCCLAY MET ALBRIGHT KD JONES JA CHRISTEN RD ALCARAZ J HOWELL SB
Citation: Ef. Mcclay et al., TAMOXIFEN MODULATION OF CISPLATIN RESISTANCE IN PATIENTS WITH METASTATIC MELANOMA - A BIOLOGICALLY IMPORTANT OBSERVATION, Cancer, 72(6), 1993, pp. 1914-1918
A PHASE-I AND PHARMACOKINETIC STUDY OF INTRAPERITONEAL CARBOPLATIN AND ETOPOSIDE
Authors: MCCLAY EF GOEL R ANDREWS P GORELICK S KIRMANI S KIM S BRALY P PLAXE S HOFF S ALCARAZ J HOWELL SB
Citation: Ef. Mcclay et al., A PHASE-I AND PHARMACOKINETIC STUDY OF INTRAPERITONEAL CARBOPLATIN AND ETOPOSIDE, British Journal of Cancer, 68(4), 1993, pp. 783-788
Risultati: 1-20 |